Novel immunomodulatory drugs and neo-substrates | Biomarker Research | Full Text

Novel immunomodulatory drugs and neo-substrates | Biomarker Research | Full Text

Novel immunomodulatory drugs and neo-substrates

Thalidomide, lenalidomide and pomalidomide are immunomodulatory drugs (IMiDs) effective in the treatment of multiple myeloma, myelodysplastic syndrome (MDS) with deletion of chromosome 5q and other hematologic...

Authors:Shaobing Gao, Shichao Wang and Yongping Song

Citation:Biomarker Research 2020 8:2

Content type:Review

Published on: 9 January 2020

• ViewFull Text
 
• ViewPDF